Get startedLog in
    Picture of Novartis AG logo

    NOVN — Novartis AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Novartis Cosentyx® Pmr Data In New England Journal Of Medicine Showed Sustained Remission Versus Placebo In Twice As Many Patients

    Picture of Novartis AG logoNovartis AG
    03/06/2026 16:37
    BRIEF-Novartis Cosentyx® Pmr Data In New England Journal Of Medicine Showed Sustained Remission Versus Placebo In Twice As Many Patients
    June 3 (Reuters) - NOVARTIS AG NOVN.S:
    • NOVARTIS COSENTYX® PMR DATA IN NEW ENGLAND JOURNAL OF MEDICINE SHOWED SUSTAINED REMISSION VERSUS PLACEBO IN TWICE AS MANY PATIENTS
    • COSENTYX ACHIEVES STATISTICALLY SIGNIFICANT EFFICACY IN ALL ENDPOINTS INCLUDING REDUCED STEROID USE
    • SUBMITS COSENTYX FOR PMR TO US, EU, JAPAN; MORE FILINGS EXPECTED IN 2026
    Source text: ID:nGNE2KtMk
    Further company coverage: NOVN.S

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Novartis AG

    See all news